Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol Inhalation Solution for Adult Lower Respiratory Tract Infection with Viscous Sputum
CTR20181202Phase 2Active
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambroxol in pulmonary infection, sponsored by Tianjin Institute of Pharmaceutical Research. Started Jul 2018; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20181202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181202.